JPMorgan Downgrades Allos Therapeutics (ALTH) to Neutral
ALTH Hot Sheet
Rating Summary:0 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
JPMorgan downgraded Allos Therapeutics (NASDAQ: ALTH) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Allos Therapeutics click here. For more ratings news on Allos Therapeutics click here.
Shares of Allos Therapeutics closed at $1.51 yesterday, with a 52 week range of $1.25-$4.10.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on Allos Therapeutics click here. For more ratings news on Allos Therapeutics click here.
Shares of Allos Therapeutics closed at $1.51 yesterday, with a 52 week range of $1.25-$4.10.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong
- Needham & Company Reiterates a 'Buy' on UQM Technologies (UQM); Increasing EV Adoption
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
